Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Indian State Cracks Down On Drug Maker Chemical Waste

This article was originally published in PharmAsia News

Executive Summary

Drug makers in the Indian state of Andhra Pradesh are being pressured by the government to enforce their industry's own policies and avoid dumping hazardous chemicals. The state's Pollution Control Board has been working with the Bulk Drug Manufacturers Association to stop illegal dumping after 140 tons of hazardous chemical waste were found near Hyderabad. Authorities say they have trouble tracking down the offending companies when many in an area have similar chemical waste. The head of BDMA said the organization has warned its members about the problem and has been proactive in disposing of the waste. (Click here for more

Table

View full table

Tags:
Latest Headlines

Executives On The Move: Three New CEOs Among This Week's Changes

Sanofi To Pursue Smart M&A Pacts And Stick With Early-Stage Oncology R&D

Xaira Launches With $1bn-Plus And End-To-End AI Strategy

Biogen Sees Improving Momentum In Slow Leqembi Launch

See All
UsernamePublicRestriction

Register

SC069738

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By